MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,820 Cr | ₹11,910 Cr | ₹9,925 Cr | ₹8,017 Cr | ₹6,737 Cr |
What is the latest Appropriations of MANKIND PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹13,820 Cr |
| Mar2025 | ₹11,910 Cr |
| Mar2024 | ₹9,925 Cr |
| Mar2023 | ₹8,017 Cr |
| Mar2022 | ₹6,737 Cr |
How is Appropriations of MANKIND PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,820 Cr | 16.04 | |
| Mar2025 | ₹11,910 Cr | 20.00 | |
| Mar2024 | ₹9,925 Cr | 23.80 | |
| Mar2023 | ₹8,017 Cr | 19.00 | |
| Mar2022 | ₹6,737 Cr | - | |
Compare Appropriations of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,236.1 Cr | 1.9% | 3.5% | -7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.9% |
3.5% |
-7% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses